ImageneBio, Inc. Common Stock
€5.057
EUR
Last updated on --.
24h volume19.74K
24h highest5.1640 EUR
24h lowest4.5499 EUR
24h Price movement+1.03%
IMA recent prices
24 Hours
+1.03%+€0.051606
30 days
+1.91%+€0.094611
60 days
+17.20%+€0.73969
90 days
-12.80%-€0.73969
Key data
Previous close5.0058 EUR
Market cap52.48M EUR
Volume19.74K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-3.3458 EUR
Net income (FY)-37.05M EUR
Revenue (FY)0.00 EUR
Last report dateMar 10, 2026
About ImageneBio, Inc. Common Stock
HeadquartersSAN DIEGO
Employees (FY)17.00
Revenue per employee (FY)0.00 EUR
Net income per employee (FY)-2.18M EUR
Listed onNasdaq
IMA conversion tables
 |  |
|---|---|
| 0.5 IMA | 2.528 EUR |
| 1 IMA | 5.057 EUR |
| 5 IMA | 25.28 EUR |
| 10 IMA | 50.57 EUR |
| |
|---|---|
| 0.5 EUR | 0.098865 IMA |
| 1 EUR | 0.19773 IMA |
| 5 EUR | 0.98865 IMA |
| 10 EUR | 1.977 IMA |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
IMA is trading at €5.057, +1.03% over the last 24 hours. Track live moves on the price chart at the top of this page.
The IMA stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. IMA is currently trading at €5.057, +1.03% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on IMA price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. IMA's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from IMA; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against IMA's historical range and other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
ImageneBio, Inc. Common Stock's market cap is currently 52.48M EUR. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume19.74K
24h highest5.1640 EUR
24h lowest4.5499 EUR
24h Price movement+1.03%
Start trade with IMA Perpetual
Sign up to trade